Drug trial aims to tame hormone chaos in Cushing's patients
NCT ID NCT05255900
Summary
This study is observing patients with mild Cushing's syndrome who are taking the medication metyrapone. Over 24 weeks, researchers will check if the drug helps control blood pressure, blood sugar, mood, bone health, and other body systems affected by high cortisol. The goal is to see if this treatment can better manage the wide-ranging health problems caused by the condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCORTISOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istituto Auxologico Italiano
Milan, 20149, Italy
Conditions
Explore the condition pages connected to this study.